Tirzepatide: A dual GIP/GLP-1 receptor agonist administered once weekly
Slovenian researchers showed that genetic variability in GLP1R is associated with inter-individual differences in the weight-lowering-lowering potential of GLP-1 drugs in obese women with polycystic ovary syndrome (PCOS) in 2015, at a time when the main GLP-1 drug was liraglutide, which required daily injection
Hormonal balance/PCOS support formulas , sometimes combined with folate, B6, B12, chromium and berberine Mood support formulas , combined with B-complex vitamins, magnesium, or adaptogen herbs to help manage stress and promote emotional resilience
doi: 10.1056/NEJMoa2028395
The rates are higher in adults, females, and people of Asian or Black ethnicity
Gibson, Manuscript collections: the archival collections at the Center for Dubuque History